Valor Compounding Pharmacy is recalling 2,916 mLs of compounded Tacrolimus 0.5 mg/mL Suspension because the medication was found to be subpotent. This means the liquid suspension contains less than the intended amount of active medication, which may prevent it from working as prescribed. The product was distributed in California in bottle sizes ranging from 2 oz to 16 oz. No injuries or medical incidents have been reported to date.
If a patient takes subpotent Tacrolimus, they receive an insufficient dose of the medication required to manage their condition. Because Tacrolimus is used to prevent organ rejection after a transplant, receiving too little medication could lead to serious health complications or transplant failure.
You have 2 options:
Quantity: 1,966 mLs. This is a compounded medication.
Quantity: 950 mLs. This is a compounded medication.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.